Loss of T Follicular Helper Cells in the Peripheral Blood of Patients with Chronic Graft-versus-Host Disease.

Pubmed ID: 26806586

Pubmed Central ID: PMC5015683

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

Publication Date: May 1, 2016

Affiliation: Division of Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota, Minnesota. Electronic address: Verneris@umn.edu.

MeSH Terms: Humans, Male, Adult, Female, Aged, Middle Aged, Chronic Disease, Follow-Up Studies, Animals, Mice, Cytokines, Graft vs Host Disease, Lymphocyte Count, T-Lymphocytes, Helper-Inducer

Grants: UL1 TR000114, P30 CA077598, P01 AI056299, 5R01AI100879, P01 CA065493, R01 AI100879, P01 CA065493-21, T32 GM008244, P01 CA142106

Authors: Weisdorf DJ, Knorr DA, Wang H, Aurora M, MacMillan ML, Holtan SG, Bergerson R, Cao Q, Cooley S, Brunstein C, Miller JS, Wagner JE, Blazar BR, Verneris MR

Cite As: Knorr DA, Wang H, Aurora M, MacMillan ML, Holtan SG, Bergerson R, Cao Q, Weisdorf DJ, Cooley S, Brunstein C, Miller JS, Wagner JE, Blazar BR, Verneris MR. Loss of T Follicular Helper Cells in the Peripheral Blood of Patients with Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant 2016 May;22(5):825-33. Epub 2016 Jan 13.

Studies:

Abstract

B cell antihost antibody production plays a central role in chronic graft-versus-host disease (cGVHD). T follicular helper (TFH) cells drive B cell responses and are implicated in this process. Given differences in cGVHD incidence between umbilical cord blood (UCB) and adult donor transplant recipients, we evaluated TFH cell reconstitution kinetics to define graft source differences and their potential pathogenic role in cGVHD. Although we observed significantly fewer TFH cells in the blood of UCB recipients (versus matched related donors [MRD]) early after transplantation, by 1 year the numbers of TFH cells were similar. Additionally, at both early (day 60) and late (1 year) time points, TFH cell phenotype was predominantly central memory cells in both cohorts. TFH cells were functional and able to produce multiple cytokines (INF-γ, TNF-α, IL-2, IL-17, and IL-21) after stimulation. In contrast to mouse models, where an enhanced frequency of splenic TFH cells contributes to cGVHD, patients with cGVHD showed significantly depleted circulating TFH cells after both UCB and MRD transplantation. Low numbers of TFH cells early after UCB transplantation could directly contribute to less cGVHD in this cohort. Additionally, systemic therapy (including steroids and calcineurin inhibitors) may contribute to decreases in TFH cells in patients with cGVHD. These data provide further evidence supporting the importance of TFH cells in cGVHD pathogenesis.